Your browser doesn't support javascript.
loading
Limited Relevance of the Very Low Risk Prostate Cancer Classification in the Modern Era: Results from a Large Institutional Active Surveillance Cohort.
Shee, Kevin; Cowan, Janet E; Balakrishnan, Ashwin; Escobar, Domenique; Chang, Kevin; Washington, Samuel L; Nguyen, Hao G; Shinohara, Katsuto; Cooperberg, Matthew R; Carroll, Peter R.
Afiliação
  • Shee K; Department of Urology, University of California-San Francisco, San Francisco, CA, USA.
  • Cowan JE; Department of Urology, University of California-San Francisco, San Francisco, CA, USA.
  • Balakrishnan A; Department of Urology, University of California-San Francisco, San Francisco, CA, USA.
  • Escobar D; Department of Urology, University of California-San Francisco, San Francisco, CA, USA.
  • Chang K; Department of Urology, University of California-San Francisco, San Francisco, CA, USA.
  • Washington SL; Department of Urology, University of California-San Francisco, San Francisco, CA, USA; Department of Epidemiology & Biostatistics, University of California-San Francisco, San Francisco, CA, USA.
  • Nguyen HG; Department of Urology, University of California-San Francisco, San Francisco, CA, USA.
  • Shinohara K; Department of Urology, University of California-San Francisco, San Francisco, CA, USA.
  • Cooperberg MR; Department of Urology, University of California-San Francisco, San Francisco, CA, USA; Department of Epidemiology & Biostatistics, University of California-San Francisco, San Francisco, CA, USA. Electronic address: matthew.cooperberg@ucsf.edu.
  • Carroll PR; Department of Urology, University of California-San Francisco, San Francisco, CA, USA. Electronic address: peter.carroll@ucsf.edu.
Eur Urol ; 84(1): 9-12, 2023 07.
Article em En | MEDLINE | ID: mdl-36870794
ABSTRACT
Although the American Urological Association recently dropped the very low-risk (VLR) subcategory for low-risk prostate cancer (PCa) and the European Association of Urology does not substratify low-risk PCa, the National Comprehensive Cancer Network (NCCN) guidelines still maintain this stratum, which is based on the number of positive biopsy cores, tumor extent in each core, and prostate-specific antigen density. This subdivision may be less applicable in the modern era in which imaging-targeted prostate biopsies are common practice. In our large institutional active surveillance cohort of patients diagnosed from 2000 to 2020 (n = 1276), the number of patients meeting NCCN VLR criteria decreased significantly in recent years, with no patient meeting VLR criteria after 2018. By contrast, the multivariable Cancer of the Prostate Risk Assessment (CAPRA) score effectively substratified patients over the same period and was predictive of upgrading on repeat biopsy to Gleason grade group ≥2 on multivariable Cox proportional-hazards regression modeling (hazard ratio 1.21, 95% confidence interval 1.05-1.39; p < 0.01), independent of age, genomic test results, and magnetic resonance imaging findings. These findings suggest that the NCCN VLR criteria are less applicable in the targeted biopsy era, and that the CAPRA score or similar instruments are better contemporary risk stratification tools for men on active surveillance. PATIENT

SUMMARY:

We investigated whether the National Comprehensive Cancer Network classification of very low risk (VLR) for prostate cancer is relevant in the modern era. We found that in a large group of patients on active surveillance, no man diagnosed after 2018 satisfied the VLR criteria. However, the Cancer of the Prostate Risk Assessment (CAPRA) score discriminated patients by cancer risk at diagnosis and was predictive of outcomes on active surveillance, and thus may be a more relevant classification scheme in the modern era.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Próstata / Neoplasias da Próstata Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Eur Urol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Próstata / Neoplasias da Próstata Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Eur Urol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos